In a filing, Plus Therapeutics Inc revealed its Director Hawkins Richard J acquired Company’s shares for reported $5996.0 on Sep 13 ’24. In the deal valued at $1.50 per share,4,000 shares were bought. As a result of this transaction, Hawkins Richard J now holds 15,188 shares worth roughly $21718.84.
Then, Hawkins Richard J bought 6,285 shares, generating $8,512 in total proceeds. Upon buying the shares at $1.35, the Director now owns 11,188 shares.
Before that, Petersen Greg bought 12,500 shares. Plus Therapeutics Inc shares valued at $16,875 were divested by the Director at a price of $1.35 per share. As a result of the transaction, Petersen Greg now holds 48,921 shares, worth roughly $69957.03.
D. Boral Capital initiated its Plus Therapeutics Inc [PSTV] rating to a Buy in a research note published on March 17, 2025; the price target was $9. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who began to cover the stock in late January with a ‘”a Buy”‘ rating. Maxim Group began covering PSTV with “Buy” recommendation on October 16, 2020.
Price Performance Review of PSTV
On Tuesday, Plus Therapeutics Inc [NASDAQ:PSTV] saw its stock jump 25.44% to $1.43. Over the last five days, the stock has gained 156.23%. Plus Therapeutics Inc shares have risen nearly 24.35% since the year began. Nevertheless, the stocks have fallen -21.43% over the past one year. While a 52-week high of $2.67 was reached on 03/07/25, a 52-week low of $0.24 was recorded on 03/04/25. SMA at 50 days reached $1.0947, while 200 days put it at $1.3788.
Levels Of Support And Resistance For PSTV Stock
The 24-hour chart illustrates a support level at 1.2567, which if violated will result in even more drops to 1.0833. On the upside, there is a resistance level at 1.5867. A further resistance level may holdings at 1.7433. The Relative Strength Index (RSI) on the 14-day chart is 57.76, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1690, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 47.72%. Stochastics %K at 46.40% indicates the stock is a holding.
How much short interest is there in Plus Therapeutics Inc?
A steep rise in short interest was recorded in Plus Therapeutics Inc stocks on 2025-03-14, growing by 0.87 million shares to a total of 0.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 59847.0 shares. There was a rise of 93.56%, which implies that there is a positive sentiment for the stock.
